COMPARATIVE BIOAVAILABILITY OF 2 ORAL FORMULATIONS OF FLURAZEPAM IN HUMAN-SUBJECTS

被引：9
作者：
COOPER, SF
DROLET, D
DUGAL, R
机构：
来源：
BIOPHARMACEUTICS & DRUG DISPOSITION | 1984年 / 5卷 / 02期
关键词：
D O I：
10.1002/bdd.2510050206
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：127 / 139
页数：13
相关论文
共 16 条
[1]  
ADERJAN R, 1980, ARZNEIMITTELFORSCH, V30-2, P1944
[2]  
ALYAN WG, SLEEPING PILLS INSOM
[3]  
COLGUHOUN D, 1971, LECTURES BIOSTATISTI, P40
[4]   GAS-LIQUID-CHROMATOGRAPHIC DETERMINATION OF FLURAZEPAM AND ITS MAJOR METABOLITES IN PLASMA WITH ELECTRON-CAPTURE DETECTION [J].
COOPER, SF ;
DROLET, D .
JOURNAL OF CHROMATOGRAPHY, 1982, 231 (02) :321-331
[5]  
DIEM V, 1970, DOCUMENTATION GEIGY, P711
[6]   KINETICS AND CLINICAL EFFECTS OF FLURAZEPAM IN YOUNG AND ELDERLY NON-INSOMNIACS [J].
GREENBLATT, DJ ;
DIVOLL, M ;
HARMATZ, JS ;
MACLAUGHLIN, DS ;
SHADER, RI .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (04) :475-486
[7]  
HASEGAWA M, 1975, CHEM PHARM BULL, V23, P1826
[8]   BLOOD LEVEL PROFILE IN MAN FOLLOWING CHRONIC ORAL-ADMINISTRATION OF FLURAZEPAM HYDROCHLORIDE [J].
KAPLAN, SA ;
SILVA, JAF ;
JACK, MI ;
ALEXANDER, K ;
STROJNY, N ;
WEINFELD, RE ;
PUGLISI, CV ;
WEISSMAN, L .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (12) :1932-1935
[9]  
MAHON WA, 1977, CLIN PHARMACOL THER, V22, P228
[10]  
RANDALL LO, BENZODIAZEPINES, P27
12